Exploring Emerging Marketing Opportunities in Osteoporosis and Arthritis- 27th International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders

Osteoporosis and musculoskeletal disorders are the major causes of disabilities in elderly population and women. This conference concentrates on the newest and advanced innovations in all the areas of osteoporosis and arthritis research. End Quote

(1888PressRelease) February 11, 2017 - Pulsus is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. Pulsus expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, Pulsus is proud to announce International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders" that is to be held during September 21-22, 2017 at Madrid, Spain.

This conference highlights the theme, "Osteoporosis and Musculoskeletal Disorders as primary health concern" that emphasizes on quality health of the world population. The conference includes workshops, symposiums, special keynote sessions conducted by eminent and notable speakers who surpass in the field of orthopaedics that include the topics Osteoporosis, Osteoarthritis, Rheumatoid Arthritis, Musculoskeletal Disorders, Prevalence and Risk Factors, Pharmacological Treatment, Alternative Treatments, Nutrition and Prevention. This International Conference additionally encourages the active participation of young student researchers since we are hosting Poster Award Competition and Young research Forum at the conference venue.

Osteoporosis Drugs Market might reach 8.9 billion US dollars in 2020 due to High Incidence of Osteoporosis. The burden of rheumatoid arthritis which is incurable autoimmune disorder increases with age and progression of disease. Rheumatoid arthritis drug market will experience slight growth over 10 years as sales increase from $11.1 billion in 2011 to $15.2 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. It is predicted that the global osteoarthritis pain drugs market to grow at a CAGR of more than 8% by 2020. There are significant unmet medical needs in this market due to the chronic nature of osteoarthritis and the absence of effective curative therapies.

Everyone who is concerned about the pain and burden of osteoporosis and musculoskeletal disorders join the conference. Connect with our social network pages to get regular industry updates.

About Pulsus: Pulsus is a publisher of scientific, technical, and medical journals. Pulsus was established in 1984 and headquartered in London, UK. Its offices are in Ontario, Canada and Hyderabad, India. Pulsus acquired Andrew John Publishing and openaccessjournals.com to expand publishing and conducting global medical meetings under cmesociety.com banner. Endorsed by medical societies, Pulsus Group is an ardent supporter of international medical research, and publishes 50+ journals in association with 20+ International medical and scientific societies.

http://osteoporosis.cmesociety.com/

###

space

Other Related Press Releases